Anterix Inc. (NASDAQ:ATEX - Get Free Report) CFO Elena Marquez sold 4,981 shares of the business's stock in a transaction dated Friday, October 9th. The stock was sold at an average price of $80.43, for a total transaction of $400,621.83. Following the completion of the sale, the chief financial officer owned 12,604 shares in the company, valued at approximately $1,013,739.72. This trade represents a 28.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Anterix Trading Up 0.5%
Shares of NASDAQ ATEX opened at $84.96 on Tuesday. The firm's 50-day moving average price is $86.79 and its 200-day moving average price is $75.07. The stock has a market capitalization of $1.67 billion, a price-to-earnings ratio of 24.27 and a beta of 0.89. Anterix Inc. has a 12-month low of $17.58 and a 12-month high of $113.00.
Anterix (NASDAQ:ATEX - Get Free Report) last announced its quarterly earnings results on Tuesday, August 11th. The company reported $0.01 EPS for the quarter, beating analysts' consensus estimates of ($0.43) by $0.44. The firm had revenue of $1.96 million during the quarter, compared to the consensus estimate of $2.00 million. Anterix had a net margin of 933.03% and a negative return on equity of 10.65%. On average, equities analysts predict that Anterix Inc. will post -2.00 EPS for the current fiscal year.
Hedge Funds Weigh In On Anterix
Hedge funds have recently added to or reduced their stakes in the stock. Integrated Wealth Concepts LLC bought a new position in Anterix in the second quarter worth approximately $35,000. Wellington Management Group LLP purchased a new stake in shares of Anterix in the 2nd quarter worth $3,192,000. Proficio Capital Partners LLC purchased a new stake in shares of Anterix in the 2nd quarter worth $309,000. Panoramic Capital LLC bought a new position in shares of Anterix during the 2nd quarter worth $15,892,000. Finally, Bank of America Corp DE bought a new position in shares of Anterix during the 2nd quarter worth $13,865,000. 87.67% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of research firms recently weighed in on ATEX. JPMorgan Chase & Co. reduced their price objective on shares of Anterix from $133.00 to $130.00 and set an "overweight" rating on the stock in a research report on Thursday, August 13th. Weiss Ratings upgraded Anterix from a "hold (c)" rating to a "hold (c+)" rating in a research report on Friday, October 2nd. Clear Str upgraded Anterix to a "strong-buy" rating in a research report on Monday, July 27th. DA Davidson set a $161.00 price target on Anterix in a report on Friday, August 21st. Finally, Wall Street Zen lowered Anterix from a "hold" rating to a "sell" rating in a research note on Saturday, August 15th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $120.00.
View Our Latest Analysis on Anterix
Anterix Company Profile
(
Get Free Report)
Anterix Inc NASDAQ: ATEX develops and enables private wireless broadband networks for critical infrastructure organizations in the United States. The company focuses on using its licensed 900 MHz spectrum to support secure, reliable communications for electric utilities and other organizations that require resilient connectivity for operational technology and field personnel.
Anterix provides spectrum access and related solutions designed to help utilities modernize communications networks, including support for grid management, outage response, remote monitoring, automation and other mission-critical applications.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Anterix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anterix wasn't on the list.
While Anterix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.